Role of interferons in endothelin-1 release from human pulmonary smooth muscle cells Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010
Sildenafil modulates PDGF and Angiotensin II induced migration and proliferation in human pulmonary artery smooth muscle cells (PA-SMC) Source: Eur Respir J 2002; 20: Suppl. 38, 227s Year: 2002
Effect of interferon α preparations on IP10 and ET-1 release from human pulmonary artery smooth muscle cells Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011
Effect of endothelin-1 and bosentan on gene expressions in the cultured pulmonary artery smooth muscle cells Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010
Overexpression of angiotensin II type 1 receptor (AGTR1) and lymphatic vasculature rarefaction is present in scleroderma with pulmonary compromised Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012
The effects of angiotensin II and related peptides on intracellular Ca2+ release in human lung fibroblasts Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013
Mir-17 modulates smooth muscle cell markers, apoptosis and BMPR-II levels in human pulmonary artery smooth muscle cells Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012
Pentastatin, matrikine of the type IV collagen a5 drives pulmonary hypertension via endothelial dysfunction Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021
Endothelin-1 downregulates BMP signaling in pulmonary artery smooth muscle cells Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012
High concentrations of VEGF reduce stretch-induced apoptosis of alveolar type II cells Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009
Influence of protein kinase C on stretch-induced apoptosis in rat alveolar type II cells Source: Annual Congress 2012 - The many roads to lung injury Year: 2012
Refractory remodeling of intrapulmonary arteries by type V collagen, apoptosis and endothelial activation in experimental systemic sclerosis Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010
TGF-β1 type II receptor (TGF-βRII) expression in pulmonary arteries of patients with severe COPD Source: Eur Respir J 2005; 26: Suppl. 49, 96s Year: 2005
Bosentan stimulates the expression of cell cycle inhibitor p27(kip1) in pulmonary artery smooth muscle cells (PASMC) Source: Annual Congress 2007 - Animal and ex vivo models of airway inflammation Year: 2007
Discrepant distribution of big endothelin (ET)-1 and ET receptors in the pulmonary artery Source: Eur Respir J 2001; 18: 5-14 Year: 2001
miR 16 modulates human pulmonary artery smooth muscle cell phenotype Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012
Angiotensin II and hypoxia synergistically induce proliferation in pulmonary artery fibroblasts by a PI-3K and PKC-signaling pathway through HIF-1 a and upregulation of angiotensin II-receptors type I Source: Eur Respir J 2002; 20: Suppl. 38, 378s Year: 2002
Type V collagen nasal tolerance regulates collagen mRNA synthesis in pulmonary remodeling of experimental systemic sclerosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008
Proliferation of alveolar type II pneumocytes is stimulated by Jagged-1 in vitro Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012
Hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: possible mechanisms Source: Eur Respir J 2004; 24: Suppl. 48, 561s Year: 2004